SIU 2019 Bladder

Viewing 1-14 of 14 articles

SIU 2019: Extent of Lymph Node Dissection in Bladder Cancer

SIU 2019: Oncofid-P-B for the Treatment of BCG Unresponsive Carcinoma In Situ (CIS) of the Bladder – Results of the European Multicenter Phase 1 Study at the End of 12 Consecutive Weeks Intensive Course

SIU 2019: Enhanced Recovery After Surgery (ERAS) Radical Cystectomy and Urinary Diversion

SIU 2019: Changing the Paradigm in Intravesical Therapy for NMIBC

SIU 2019: Re-TURBT – Yes, No, or Maybe?

SIU 2019: Debate - Adjuvant Therapy for Muscle Invasive Bladder Cancer

SIU 2019: Debate - Neoadjuvant Therapy for Muscle Invasive Bladder Cancer

SIU 2019: Debate - Chemotherapy is Better than Immunotherapy as Neoadjuvant Therapy for Muscle Invasive Bladder Cancer

SIU 2019: Debate - Immunotherapy is Better than Chemotherapy as Neoadjuvant Therapy for Muscle-Invasive Bladder Cancer

SIU 2019: Debate - Urinary Markers Are Irrelevant for Management of Bladder Cancer

SIU 2019: Debate - Urinary Markers Are Useful in Management of Bladder Cancer

SIU 2019: pT0 after Neoadjuvant Chemotherapy for Muscle Invasive Urothelial Carcinoma of the Bladder: Implications for Bladder Preservation

SIU 2019: Debate Bladder Cancer: The Optimal Management for a Healthy 65-year-old Male with High-Grade T1 Bladder Cancer is BCG Maintenance - CON

SIU 2019: Debate Bladder Cancer: The Optimal Management for a Healthy 65-year-old Male with High-Grade T1 Bladder Cancer is BCG Maintenance - Pro